Home › NDC Lookup › RxCUI directory › RxCUI 200343

Hydroxyurea 300 MG Oral Capsule — RxCUI 200343

RxNorm drug concept · Semantic clinical drug
RxCUI 200343 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI200343
Official nameHydroxyurea 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)4,236 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydroxyurea: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's actually both, depending on the specific product. Droxia, Siklos, and Xromi are each approved to reduce the painful crises and blood transfusion needs in sickle cell anemia. H...
  • What exactly is hydroxyurea used for — is it a cancer drug or a sickle cell drug?
  • Very regularly — typically every two weeks while your dose is being adjusted. Hydroxyurea can lower your white blood cell and platelet counts, so monitoring is built into the treat...
  • How often will I need blood tests while I'm on this medication?
📖 Read our full Hydroxyurea guide →

🕸️ Concept Web — How Hydroxyurea 300 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydroxyurea 300 MG Oral Capsule RxCUI 200343

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Hydroxyurea 5552
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Droxia 216755
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydroxyurea Oral Capsule 370658
    • Hydroxyurea Oral Product 1160113
    • Hydroxyurea Pill 1160114
    • Hydroxyurea Oral Capsule [Droxia] 366459
    • Droxia Oral Product 1166387
    • Droxia Pill 1166388
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydroxyurea 300 MG SCDC · 316068
  • Hydroxyurea Oral Capsule SCDF · 370658
  • Hydroxyurea Oral Product SCDG · 1160113
  • Hydroxyurea Pill SCDG · 1160114

Brand-Name Concepts

  • Hydroxyurea 300 MG Oral Capsule [Droxia] SBD · 213283
  • Hydroxyurea 300 MG [Droxia] SBDC · 573196
  • Hydroxyurea Oral Capsule [Droxia] SBDF · 366459
  • Droxia Oral Product SBDG · 1166387
  • Droxia Pill SBDG · 1166388
  • Droxia BN · 216755

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 200343 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61269-0402-60 60 CAPSULE in 1 BOTTLE (61269-402-60) DROXIA H2-Pharma LLC 2015-07-16
61269-0403-60 60 CAPSULE in 1 BOTTLE (61269-403-60) DROXIA H2-Pharma LLC 2015-07-16
61269-0404-60 60 CAPSULE in 1 BOTTLE (61269-404-60) DROXIA H2-Pharma LLC 2015-07-16
80725-0820-60 60 CAPSULE in 1 BOTTLE (80725-820-60) DROXIA Waylis Therapeutics LLC 2025-09-11
80725-0830-60 60 CAPSULE in 1 BOTTLE (80725-830-60) DROXIA Waylis Therapeutics LLC 2025-09-11
80725-0840-60 60 CAPSULE in 1 BOTTLE (80725-840-60) DROXIA Waylis Therapeutics LLC 2025-09-11
Observed labelers: H2-Pharma LLC (3) · Waylis Therapeutics LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.